BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Drug Development

  Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Initiates Phase III Trial to Determine the Optimal VELCADE(R) (Bortezomib) for Injection Based Therapy in Newly Diagnosed Multiple Myeloma Patients

  July 16, 2007

   · 

  7 min read
• Drug Development

  DiaMedica Inc. Provides Update on Phase II Clinical Study of DM-71 in Type 2 Diabetes

  July 16, 2007

   · 

  1 min read
• Miraculins Inc. Announces Private Placement Offering

  July 16, 2007

   · 

  1 min read
• Drug Development

  Protalix Biotherapeutics Receives Special Protocol Assessment Approval from FDA for its Phase III Clinical Study of prGCD

  July 16, 2007

   · 

  3 min read
• BioForest

  Calypte Biomedical Corporation Reports Positive Results of Aware(TM) HIV-1/2 Oral Fluid Rapid Test Evaluation at 3rd Annual South African AIDS Conference

  July 16, 2007

   · 

  5 min read
• BioMidwest

  Simbionix Launches Portable LAP Simulator at the European Association for Endoscopic Surgery Meeting

  July 16, 2007

   · 

  1 min read
• Drug Development

  Pipex Pharmaceuticals’ Oral TRIMESTA Initiates Dosing in Phase II/III Clinical Trial for Multiple Sclerosis

  July 16, 2007

   · 

  1 min read
• Policy

  Boston Scientific Corporation Announces Agreement to Settle Product Lawsuits

  July 16, 2007

   · 

  2 min read
• BioForest

  Nasdaq Approves Forbes Medi-Tech Inc. Transfer to Nasdaq Capital Market

  July 16, 2007

   · 

  1 min read
• Deals

  IBEX Technologies Completes Fifth and Final Payment for Arthritis Biomarkers

  July 16, 2007

   · 

  1 min read